ScienceTop StoryTop StoryLatest News
Researchers Discover Why Some People Avoid Alzheimer’s Despite Genetic Risk
Sentiment: NeutralHigh Priority
What Happened?
Columbia University researchers have identified a rare genetic mutation that may protect some individuals from Alzheimer's disease, despite carrying a high-risk gene. This discovery could lead to new treatment avenues.
Key points
- Some individuals with the APOE ε4 gene variant do not develop Alzheimer's.
- A rare mutation in the fibronectin (FN1) gene may protect against Alzheimer's.
- Excess fibronectin can damage the blood-brain barrier, increasing Alzheimer's risk.
- The study used various methods, including human tissue analysis and animal models.
- Findings suggest potential new treatment strategies targeting fibronectin accumulation.
Key insights
- The discovery may inspire therapies that mimic the protective effects of the FN1 mutation.
- Identifying the mechanisms of fibronectin's harmful effects could lead to targeted treatments.
- The findings highlight the importance of genetic factors in Alzheimer's disease progression.
Why it matters
Understanding how some individuals resist Alzheimer's could lead to new prevention and treatment strategies.
Tags
Entities
Columbia University· OrganizationAPOE ε4· Genefibronectin· ProteinNature Aging· Event
Source
Science Daily
